1 – 10 of 15
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Response to the Comment on "aLPPS Improves Survival Compared with TSH in Patients Affected of CRLM : Survival Analysis from the Randomized Controlled Trial LIGRO-Metastatic Tumor Burden in the Future Liver Remnant for Decision-making of Staged Hepatectomy"
(
- Contribution to journal › Letter
-
Mark
Response to Comment on "aLPPS Improves Survival Compared with TSH in Patients Affected of CRLM - It Is Time to Entry the IDEAL Stage 4?"
(
- Contribution to journal › Letter
- 2020
-
Mark
Segment 4 occlusion in portal vein embolization increase future liver remnant hypertrophy : A Scandinavian cohort study
(
- Contribution to journal › Article
-
Mark
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
(
- Contribution to journal › Article
-
Mark
A risk score model to predict incidental gallbladder cancer in patients scheduled for cholecystectomy
(
- Contribution to journal › Article
-
Mark
Outcomes of Simultaneous Resections and Classical Strategy for Synchronous Colorectal Liver Metastases in Sweden : A Nationwide Study with Special Reference to Major Liver Resections
2020) In World Journal of Surgery(
- Contribution to journal › Article
- 2019
-
Mark
Future Liver Remnant (FLR) Increase in Patients with Colorectal Liver Metastases Is Highest the First Week After Portal Vein Occlusion : FLR Increase in Patients with CRLM Is Highest the First Week After PVO
(
- Contribution to journal › Article
-
Mark
Incidental metastases and lymphoma of the gallbladder–an analysis of ten rare cases identified from a large national database
(
- Contribution to journal › Article
- 2018
-
Mark
Significance of poor performance status after resection of colorectal liver metastases
(
- Contribution to journal › Article
-
Mark
ALPPS Improves Resectability Compared with Conventional Two-stage Hepatectomy in Patients with Advanced Colorectal Liver Metastasis : Results from a Scandinavian Multicenter Randomized Controlled Trial (LIGRO Trial)
(
- Contribution to journal › Article